Nana Ishikawa - Director of Clinical Development - Impute Inc.

Nana Ishikawa - Director of Clinical Development - Impute Inc.

4.7
(543)
Write Review
More
$ 28.00
Add to Cart
In stock
Description

Late-Breaking Science Abstracts and Featured Science Abstracts

Abstracts from the 11th International Congress of Behavioral

PDF) The United States Federal Drug Administration (FDA) and

Genentech: Anubha Mahajan Senior Principal Scientist Human

Abstracts from the 11th International Congress of Behavioral

The Japanese Clinical Practice Guidelines for Management of Sepsis

EDRA 38 - Bissell - Environmental Design Research Association

Haematologica, Volume 104, Issue 12 by Haematologica - Issuu

Nutrients June 2020 - Browse Articles

Abstracts from the 11th International Congress of Behavioral

PDF) Safety and Benefit of Discontinuing Statin Therapy in the

Abstracts from the 11th International Congress of Behavioral

Impute Inc.

Impute Inc.

Late-Breaking Science Abstracts and Featured Science Abstracts